Rani Therapeutics Holdings (RANI) Research & Development (2020 - 2025)
Historic Research & Development for Rani Therapeutics Holdings (RANI) over the last 6 years, with Q3 2025 value amounting to $3.2 million.
- Rani Therapeutics Holdings' Research & Development fell 4781.27% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.1 million, marking a year-over-year decrease of 1955.31%. This contributed to the annual value of $26.7 million for FY2024, which is 3266.2% down from last year.
- Per Rani Therapeutics Holdings' latest filing, its Research & Development stood at $3.2 million for Q3 2025, which was down 4781.27% from $5.5 million recorded in Q2 2025.
- In the past 5 years, Rani Therapeutics Holdings' Research & Development registered a high of $12.0 million during Q3 2021, and its lowest value of $3.2 million during Q3 2025.
- Over the past 5 years, Rani Therapeutics Holdings' median Research & Development value was $7.6 million (recorded in 2024), while the average stood at $7.6 million.
- In the last 5 years, Rani Therapeutics Holdings' Research & Development surged by 47220.1% in 2021 and then crashed by 4781.27% in 2025.
- Over the past 5 years, Rani Therapeutics Holdings' Research & Development (Quarter) stood at $7.4 million in 2021, then skyrocketed by 40.03% to $10.4 million in 2022, then dropped by 26.77% to $7.6 million in 2023, then decreased by 10.47% to $6.8 million in 2024, then tumbled by 52.7% to $3.2 million in 2025.
- Its Research & Development stands at $3.2 million for Q3 2025, versus $5.5 million for Q2 2025 and $6.6 million for Q1 2025.